The Payment Question

The scientific community is churning out massive amounts of data and, increasingly, that data is being made publicly available. The director of the US Office of Science and Technology Policy John Holdren, for example, called in February for federal agencies to come up with a plan to publicly share research results and data from studies funded by the government.

But, as Francine Berman from Rensselaer Polytechnic Institute and Google's Vint Cerf ask in Science: Who is going to pay for it?

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

This Week in Nucleic Acids Research: Researchers describe a new method to find large-scale structural variants in cancer genomes, a glimpse at an approach for profiling miRNAs in tumor samples from TCGA, and more.

Intellia Therapeutics has raised $70 million, becoming the latest firm leveraging the gene editing technology to haul in a gob of cash.

Now going beyond reporting fetal aneuploidies, NIPTs may be providing too much information that may be useless, some doctors and genetic counselor say.

A group of organizations in the UK say that there needs to be discussions about the use of technologies such as CRISPR/Cas-9 for human germline editing.